Monograph Details
|
|
Urogenital System
> Benign prostatic hyperplasia/urinary retention
|
|
URECHOLINE |
| Manufacturer |
|
Duramed Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Cholinergic. |
| Generic Name |
|
Bethanechol chloride 5mg, 10mg, 25mg, 50mg; scored tabs. |
| Indications |
|
Post-op and post-partum nonobstructive urinary retention and retentive neurogenic urinary atony. |
| Children |
|
Not recommended. |
| Adults |
|
Take on empty stomach. Initially 5–10mg every hour until effective or max 50mg, then 10–50mg 3–4 times daily. |
| Contraindications |
|
Hyperthyroidism. Peptic ulcer. Asthma. Bradycardia. Hypotension. Vasomotor instability. Coronary artery disease. Epilepsy. Parkinsonism. Obstructive uropathies. Questionable GI or bladder integrity. Obstructive, spastic, inflammatory GI disorders. Vagotonia. Peritonitis. When increased GI or bladder muscle activity may be harmful. |
| Precautions |
|
Reflux urinary infection. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Severe abdominal symptoms and hypotension with ganglionic blockers. |
| Adverse Reactions |
|
Cholinergic effects, GI upset, asthma, headache, facial flushing, malaise, orthostatic hypotension. |
| How Supplied |
|
Tabs—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
